FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma

Detalles Bibliográficos
Autores principales:	Couillard, S, Shrimanker, R, Chaudhuri, R, Mansur, AH, McGarvey, LP, Heaney, LG, Fowler, SJ, Bradding, P, Pavord, ID, Hinks, TSC
Formato:	Conference item
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021

Ejemplares similares